Shares of Innoviva, Inc. (INVA) have traded between $10.03 – 16.3. The next earnings date is set for May 06, 2020. Let’s see how its prospects are shaping up.

What does Innoviva, Inc.(INVA) do?

Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA.

INVA Insider Trading Insight

On 2019-02-21, Bickerstaff George Dir purchased 10,000 shares of INVA. That represents a value of $38,762. Not to be outdone, on 2019-02-15, Hulme Geoffrey P – Purchase bought7,000 shares of INVA. These insiders are clearly in the know because they work closely with the company.

ROP Intraday Trading

ROP is due to report earnings on Apr 23, 2020. In the last year the price has ranged from 310.92 – 395. Recently, Wright Christopher sold 500 shares of ROP. He is a $881,158 shareholder in ROP.

Looking for stocks similar to INVA and ROP?

Here are some stocks to consider:
GSK
MRK
XYL
IEX